Navigation Links
Sirion Therapeutics Announces FDA Approval of Zirgan(TM) (Ganciclovir Ophthalmic Gel) 0.15% for Herpetic Keratitis
Date:9/21/2009

ecomes latent until triggers such as stress, UV radiation, and hormonal changes reactivate the virus and cause recurrent outbreaks. Those recurrences account for an additional 28,000 cases per year in the US. The risk of blindness increases with the number and severity of recurrences, making prompt treatment imperative to limit scarring and other more serious complications caused by herpetic ulcers.

About Zirgan(TM) (ganciclovir ophthalmic gel) 0.15%

Zirgan is the trademark of Laboratoires Thea of France and Sirion Therapeutics, Inc., has the exclusive US rights to develop and market Zirgan. Available in Europe under the brand name Virgan(R), this topical ophthalmic antiviral gel has successfully treated herpetic viral infections for more than 10 years. In 2007 Sirion received orphan drug designation from the FDA for ganciclovir ophthalmic gel. This designation is a special status for rare diseases or conditions that affect fewer than 200,000 patients in the US.

Important Safety Information

Zirgan is indicated for topical ophthalmic use only. Patients should not wear contact lenses if they have signs or symptoms of herpetic keratitis or during the course of therapy with Zirgan. The most common adverse reactions reported in patients were blurred vision (60%), eye irritation (20%), punctate keratitis (5%), and conjunctival hyperemia (5%).

About Sirion Therapeutics, Inc.

Sirion Therapeutics, Inc. is a privately held biopharmaceutical company pursuing the discovery, development, and commercialization of products addressing unmet medical needs in the protection and preservation of eyesight. Sirion's diverse portfolio includes products that address ocular diseases and conditions including uveitis, herpetic keratitis, dry eye, glaucoma, and geographic atrophy associated with dry AMD. For more information, please visit

SOURCE Sirion Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation
2. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
3. Prime Therapeutics Receives TIPPS Certification
4. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
5. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
6. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
7. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
8. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
9. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
10. Prime Therapeutics Announces URAC Accreditation
11. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... 04, 2015 , ... World Patent Marketing, a vertically integrated ... fitness invention that eliminates the need to have a partner or trainer when ... is worth $30 billion," says Scott Cooper, CEO and Creative Director of World ...
(Date:8/4/2015)... Birmingham, OH (PRWEB) , ... August 04, 2015 ... ... announce that it has joined the American Association of Tissue Banks (AATB) as ... AATB and its mission “to honor donors, and to save and improve lives ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... technology platform that uses Cloud innovation to consolidate oncology patient assistance programs. Through ... a single point of access. assistPoint is an enterprise level, cloud-based application and ...
(Date:8/4/2015)... ... August 04, 2015 , ... Atlantic Health System, one of the largest health ... among the top five in their list of the 20 Best Workplaces in Health ... Chilton Medical Centers, Goryeb Children’s Hospital and Atlantic Rehabilitation, is the highest-ranking company from ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... on sexual and reproductive health and rights in Indonesia for a select group ... a number of sites in Indonesia and attend the International Conference on Family ...
Breaking Medicine News(10 mins):Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:assistPoint.com Web Site Launched 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 4Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2
... reward pathways as booze , TUESDAY, June 22 (HealthDay News) ... option for alcoholism, a new animal study suggests. , Alcoholism ... and eat), which leads to disrupted sleep patterns. As a ... attempt to fall asleep easier. But this often leads to ...
... 2 chances, study finds , TUESDAY, June 22 (HealthDay News) ... the waist, significantly increases your risk of type 2 diabetes, ... stable after age 50, people who gained the most weight ... of developing type 2 diabetes, according to the study in ...
... response to the H1N1 flu, most employees at U.S. businesses ... such as encouraging sick employees to stay home, according to ... Opinion Research Program at Harvard School of Public Health (HSPH). ... took other actions such as creating back-up systems for employees ...
... ... in the US to utilize Mayo Clinic Embody Health Program. , ... (PRWEB) June 22, 2010 -- St Gregory Centers, Inc. ... provide wellness programming for St Gregory clients and employees. The Mayo Clinic program will ...
... care of sick or disabled loved ones is widely recognized ... life, a new study led by University at Buffalo psychologist ... loved ones may promote the well being of helpers. "Does ... journal Psychology and Aging (2010, Vol. 25., No. ...
... risk of obesity, but a new study shows that a ... their parents helps the children reduce body fat and improve ... Society,s 92nd Annual Meeting in San Diego. Such interventions ... the study,s lead author Jardena Puder, MD, said. A senior ...
Cached Medicine News:Health News:Exercise May Combat Alcohol Cravings, Animal Study Suggests 2Health News:Gaining Weight Later in Life Ups Diabetes Risk 2Health News:Gaining Weight Later in Life Ups Diabetes Risk 3Health News:Employers took many measures to protect employees and avoid business impact of H1N1 flu outbreak 2Health News:Employers took many measures to protect employees and avoid business impact of H1N1 flu outbreak 3Health News:Employers took many measures to protect employees and avoid business impact of H1N1 flu outbreak 4Health News:St. Gregory Centers, Inc. Announces Integrating Mayo Clinic Health Wellness Program 2Health News:Study finds that caring for an elderly, sick spouse sometimes has positive elements 2Health News:Lifestyle intervention reduces preschoolers' body fat, improves fitness 2
(Date:8/4/2015)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... Chief Executive Officer, Doug Godshall , is scheduled ... Conference at 8:30 a.m. EDT on Thursday, August 13, ... at the InterContinental Boston. A live webcast ...
(Date:8/4/2015)... , Aug. 04, 2015 ... has announced the addition of the "MRI ... Comfort and Operational Efficiency, with Growth Driven by ... "MRI Systems Market to 2020 - Focus ... Driven by Developing Economies" discusses the market, competitive ...
(Date:8/4/2015)...  Dr. Keesha Ewers of The ... of flibanserin, or what is being touted as ... decreased female sexual desire back several decades. Diminished ... addressing libido as a singular symptom with a ... Photo - http://photos.prnewswire.com/prnh/20150804/254705 ...
Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5
... Open-Label Study Presented at Federation of,Clinical Immunology ... June 11, 2007 /PRNewswire-FirstCall/ --,Orchestra Therapeutics, Inc. ... from its completed Phase II open-label study ... peptide,vaccine for the treatment of relapsing-remitting multiple ...
... -- NovaCardia, Inc.,today presented preliminary results from a ... receptor antagonist in development for the,treatment of patients ... strong trend toward efficacy for the 30 milligram,dose. ... of,improvement in dyspnea, or shortness of breath, which ...
Cached Medicine Technology:Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 2Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 3Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 4
... 12 mm linear cutting stapler for resection, ... ,The stapler places two triple, staggered rows ... divides the tissue in between. The instrument ... single surgical procedure: it can be reloaded ...
Single Use Loading Units with Titanium Staples for use with Powered MULTIFIRE ENDO GIA™ 60 (15 mm Single Use Stapler with Titanium Staples)....
Single Use Loading Units (SULU's) with Titanium Staples for use with MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)....
ENDO GIA ROTICULATOR™ Single Use Loading Units with Titanium Staples for use with the ENDO GIA™ Universal and GIA™ Universal Instrument (030403) Single Use Instrument (030449)....
Medicine Products: